Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02990130 · ClinicalTrials.gov registry record
Patient Fitness and Body Composition During Hematopoietic Stem Cell Transplantation
A clinical trial of Hematologic Malignancy, sponsored by Garcia, Jose M., MD, PhD.
- Active
- Registry status
- 60
- Enrollment target
- 1
- Study location
NCT02990130 is a study of Hematologic Malignancy that is active but no longer recruiting, run by Garcia, Jose M., MD, PhD. The registered enrollment target is 60 participants, below the 227-participant average among 48 other Hematologic Malignancy trials with a reported enrollment target (74% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02990130, a study of Hematologic Malignancy, is active but no longer recruiting, sponsored by Garcia, Jose M., MD, PhD.
- ACTIVE NOT RECRUITING
- Registry status
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
This proposal aims to characterize biochemical and physiologic factors that contribute to changes in patient fitness and body composition during hematopoietic stem cell transplantation (HCT) for hematologic malignancies. The study group will consist of 60 patients with hematologic malignancies treated with HCT. Measurements of patient fitness, body composition, and inflammatory milieu will be performed at visits before HCT, and 30 days (+/- 10 days) after HCT. For patients that continue to receive care at the Seattle VA, additional visits (not exceeding 6 total) may be requested periodically for up to 2 years after HCT.
Conditions Studied
Interventions
- OTHER Observational
Study Locations (1)
Washington
- VA Puget Sound Health Care System - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2016-11 |
| Est. Completion | 2025-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02990130
The ClinicalTrials.gov registry entry for NCT02990130 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 227-participant average among 48 other Hematologic Malignancy trials with a reported enrollment target (74% lower). The listed sponsor is Garcia, Jose M., MD, PhD, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Hematologic Malignancy appearing as the primary indexed condition, and to 1 intervention - of which Observational is the first listed.
NCT02990130 reports 1 study location spanning 1 distinct geographic area - top geographies include Washington.
Frequently Asked Questions
What is clinical trial NCT02990130 about?
NCT02990130 is a clinical study titled "Patient Fitness and Body Composition During Hematopoietic Stem Cell Transplantation". This proposal aims to characterize biochemical and physiologic factors that contribute to changes in patient fitness and body composition during hematopoietic stem cell transplantation (HCT) for hematologic malignancies. The study group will consist of 60 patients with hematologic malignancies treat...
What is the current status of trial NCT02990130?
This trial is currently active not recruiting. The enrollment target is 60 participants. The study started on 2016-11. Estimated completion is 2025-07.
What conditions does trial NCT02990130 study?
This clinical trial studies the following conditions: Hematologic Malignancy.
What interventions are being tested in trial NCT02990130?
The interventions under investigation include: Observational (OTHER).
Who is sponsoring clinical trial NCT02990130?
This trial is sponsored by Garcia, Jose M., MD, PhD, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02990130 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hematologic Malignancy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
FDG-PET as an Imaging Modality to Diagnose and Risk Stratify Subclinical, Imaging Negative Ici-Myocarditis
RECRUITING
-
An Extension Study for Patients Previously Enrolled in Studies With Pelabresib
RECRUITING · Phase 3
-
TCRαβ-depleted Progenitor Cell Graft With Early Memory T-cell DLI, Plus Selected Use of Blinatumomab, in naïve T-cell Depleted Haploidentical Donor Hematopoietic Cell Transplantation for Hematologic Malignancies
RECRUITING · Phase 1
-
CAR T-cell Therapy Directed to CD70 for Pediatric Patients With Hematological Malignancies
RECRUITING · Phase 1
-
Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
RECRUITING · Phase 1
-
Let's Get REAL: Family Health Communication Tool in Pediatric Stem Cell Transplant and Cellular Therapy
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.